Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mondher Toumi

Showing results (1-10 of 239) with videos related to

Pageof 24
Sort By:
Journal of Market Access & Health Policy|May 27, 2016
The Market Access Society launches a new journalMondher Toumi
Journal of Market Access & Health Policy|March 6, 2024
Welcome to the Journal of Market Access and Health Policy under MDPI WingsMondher Toumi
Medecine Sciences : M/S|June 19, 2018
[Towards more targeted therapies in a contraint economy]Mondher Toumi
International Journal of Psychiatry in Clinical Practice|June 17, 2014
Post-marketing surveillance of sertindoleMondher Toumi
HIV/AIDS (Auckland, N.Z.)|April 14, 2016
Economic and health implications from earlier detection of HIV infection in the United KingdomVladimir Zah, Mondher Toumi
Journal of Market Access & Health Policy|May 27, 2016
Economic impact of new active substance status on EU payers' budgets: example of dimethyl fumarate (Tecfidera(®)) for multiple sclerosisMondher Toumi, Guy Jadot
Journal of Market Access & Health Policy|May 27, 2016
Benefits of probabilistic sensitivity analysis - a review of NICE decisionsErpur Adalsteinsson, Mondher Toumi
Journal of Market Access & Health Policy|June 16, 2020
Commentary on "Hydroxychloroquine and azithromycin as a treatment of COVID-19: results of an open label non-randomized clinical trial" by Gautret et alMondher Toumi, Samuel Aballea
Expert Review of Pharmacoeconomics & Outcomes Research|January 26, 2024
Drug pricing and transparency in Europe and the United States: what is it and how does it work?Steven Simoens, Mondher Toumi
Journal of Market Access & Health Policy|April 29, 2016
National Immunization Therapeutic Advisory Group: it is time for experience sharing and best practice learningWalter Ricciardi, Mondher Toumi
Pageof 24

Showing results (1-10 of 239) with videos related to

Sort By:
Pageof 24
Journal of Market Access & Health Policy|May 27, 2016
The Market Access Society launches a new journalMondher Toumi
Journal of Market Access & Health Policy|March 6, 2024
Welcome to the Journal of Market Access and Health Policy under MDPI WingsMondher Toumi
Medecine Sciences : M/S|June 19, 2018
[Towards more targeted therapies in a contraint economy]Mondher Toumi
International Journal of Psychiatry in Clinical Practice|June 17, 2014
Post-marketing surveillance of sertindoleMondher Toumi
HIV/AIDS (Auckland, N.Z.)|April 14, 2016
Economic and health implications from earlier detection of HIV infection in the United KingdomVladimir Zah, Mondher Toumi
Journal of Market Access & Health Policy|May 27, 2016
Economic impact of new active substance status on EU payers' budgets: example of dimethyl fumarate (Tecfidera(®)) for multiple sclerosisMondher Toumi, Guy Jadot
Journal of Market Access & Health Policy|May 27, 2016
Benefits of probabilistic sensitivity analysis - a review of NICE decisionsErpur Adalsteinsson, Mondher Toumi
Journal of Market Access & Health Policy|June 16, 2020
Commentary on "Hydroxychloroquine and azithromycin as a treatment of COVID-19: results of an open label non-randomized clinical trial" by Gautret et alMondher Toumi, Samuel Aballea
Expert Review of Pharmacoeconomics & Outcomes Research|January 26, 2024
Drug pricing and transparency in Europe and the United States: what is it and how does it work?Steven Simoens, Mondher Toumi
Journal of Market Access & Health Policy|April 29, 2016
National Immunization Therapeutic Advisory Group: it is time for experience sharing and best practice learningWalter Ricciardi, Mondher Toumi
Pageof 24